0001192482-18-000391.txt : 20180813 0001192482-18-000391.hdr.sgml : 20180813 20180813142453 ACCESSION NUMBER: 0001192482-18-000391 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20180813 DATE AS OF CHANGE: 20180813 EFFECTIVENESS DATE: 20180813 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Aclaris Therapeutics, Inc. CENTRAL INDEX KEY: 0001557746 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 460571712 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-292766 FILM NUMBER: 181011821 BUSINESS ADDRESS: STREET 1: 640 LEE ROAD STREET 2: SUITE 200 CITY: WAYNE STATE: PA ZIP: 19087 BUSINESS PHONE: 484-324-7933 MAIL ADDRESS: STREET 1: 640 LEE ROAD STREET 2: SUITE 200 CITY: WAYNE STATE: PA ZIP: 19087 D/A 1 primary_doc.xml X0708 D/A LIVE 0001557746 Aclaris Therapeutics, Inc. 640 LEE ROAD SUITE 200 WAYNE PA PENNSYLVANIA 19087 484-324-7933 DELAWARE None None Corporation true Neal Walker 640 Lee Road Suite 200 Wayne PA PENNSYLVANIA 19087 Executive Officer Director Christopher Powala 640 Lee Road Suite 200 Wayne PA PENNSYLVANIA 19087 Executive Officer Stuart Shanler 640 Lee Road Suite 200 Wayne PA PENNSYLVANIA 19087 Executive Officer Kamil Ali-Jackson 640 Lee Road Suite 200 Wayne PA PENNSYLVANIA 19087 Executive Officer Frank Ruffo 640 Lee Road Suite 200 Wayne PA PENNSYLVANIA 19087 Executive Officer Stephen A. Tullman 640 Lee Road Suite 200 Wayne PA PENNSYLVANIA 19087 Director Anand Mehra 640 Lee Road Suite 200 Wayne PA PENNSYLVANIA 19087 Director Christopher Molineaux 640 Lee Road Suite 200 Wayne PA PENNSYLVANIA 19087 Director Bryan Reasons 640 Lee Road Suite 200 Wayne PA PENNSYLVANIA 19087 Director Brett Fair 640 Lee Road Suite 200 Wayne PA PENNSYLVANIA 19087 Executive Officer William Humphries 640 Lee Road Suite 200 Wayne PA PENNSYLVANIA 19087 Director Andrew Powell 640 Lee Road Suite 200 Wayne PA PENNSYLVANIA 19087 Director Andrew Schiff 640 Lee Road Suite 200 Wayne PA PENNSYLVANIA 19087 Director Pharmaceuticals Decline to Disclose 06b true 0001192482-17-000228 2017-08-03 true true true 0 12500000 10000000 2500000 $10,000,000 of issuer's common stock became issuable upon closing of the merger. The merger agreement provides for the issuance of up to an additional $2,500,000 worth of stock, subject to the satisfaction of certain conditions in the merger agreement. false 41 0 0 0 false Aclaris Therapeutics, Inc. /s/ Neal Walker Neal Walker Chief Executive Officer 2018-08-13